Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 78

    CCI approves sale, restructuring of Apollo Pharmacy

    CCI approves sale, restructuring of Apollo Pharmacy

    Medical Dialogues Bureau24 Sept 2019 9:15 AM IST
    NEW DELHI: The Competition Commission on Monday said it has approved the restructuring of Apollo Hospitals Enterprise Ltd's pharmacy business and its...
    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus

    Medical Dialogues Bureau23 Sept 2019 2:16 PM IST
    Novo Nordisk did not disclose what it plans to charge for the new oral treatment, called Rybelsus, but said it would be "competitively priced" with...
    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Medical Dialogues Bureau23 Sept 2019 10:15 AM IST
    "At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    Cipla API facility in Bengaluru gets EIR from USFDA

    Cipla API facility in Bengaluru gets EIR from USFDA

    Medical Dialogues Bureau23 Sept 2019 9:45 AM IST
    Cipla had earlier said that USFDA issued seven observations after conducting a routine 'CGMP inspection' at Cipla's API manufacturing facility in...
    Torrent Pharma expands recall of Losartan tablets in US over carcinogen impurity

    Torrent Pharma expands recall of Losartan tablets in US over carcinogen impurity

    Medical Dialogues Bureau23 Sept 2019 9:00 AM IST
    "The recall is expanded to include an additional three lots of Losartan potassium tablets USP and 2 lots of Losartan potassium/hydrochlorothiazide...
    Unichem Labs API facility in Kolhapur clears CGMP surveillance by USFDA

    Unichem Labs API facility in Kolhapur clears CGMP surveillance by USFDA

    Medical Dialogues Bureau22 Sept 2019 10:00 AM IST
    New Delhi: Drug firm Unichem Laboratories recently said the US health regulator has concluded inspection of its new facility at Kolhapur, Maharashtra...
    Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD

    Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD

    Medical Dialogues Bureau22 Sept 2019 9:45 AM IST
    This partnership will enable Cipla arm (Breathe Free Lanka) to facilitate easy access to Ultibro Breezhaler for patients in Sri Lanka to help them...
    Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

    Siemens Healthineers invests Rs 20 crore for medical imaging manufacturing facility at Bengaluru

    Medical Dialogues Bureau22 Sept 2019 9:30 AM IST
    Siemens Healthineers has made a Rs 20-crore investment in a new manufacturing facility collocated with its RnD centre at Bengaluru.New Delhi: Medical...
    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster dose to sector

    Healthcare industry lauds Govt decision, says rationalisation of tax structure will provide booster dose to sector

    Garima22 Sept 2019 9:20 AM IST
    Apollo Hospitals Chairman Prathap C Reddy said, "We heartily welcome the measures announced by the honourable Finance Minister today. Corporate India...
    Condom sales down by 8 percent, estimates Industry sources

    Condom sales down by 8 percent, estimates Industry sources

    Medical Dialogues Bureau22 Sept 2019 9:15 AM IST
    Industry sources estimated condom sales are down 8% since the start of the year compared to 2018 and have fallen by a quarter over recent months.New...
    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Strides Pharma re-enters injectable biz by infusing Rs 280 crore for controlling stake in Stelis Biopharma

    Farhat Nasim21 Sept 2019 12:04 PM IST
    Bengaluru-based Strides has already invested USD 35 million (about Rs 245 crore) for a 43 per cent ownership in Stelis.New Delhi: Strides Pharma...
    PrevNext

    Popular Stories

    FDA shuts six medical stores in Haryana due to irregularities

    FDA shuts six medical stores in Haryana due to irregularities

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok